WS23.2 Characterizing Belgian CF-registry (BCFR)-patients with a rare CFTR-mutation (RM): towards better identification of the role of RM in disease liability.

MLA

De Wachter, E., et al. “WS23.2 Characterizing Belgian CF-Registry (BCFR)-Patients with a Rare CFTR-Mutation (RM): Towards Better Identification of the Role of RM in Disease Liability.” Journal of Cystic Fibrosis, vol. 15, June 2016, p. S35. EBSCOhost, https://doi.org/10.1016/S1569-1993(16)30183-7.

APA

De Wachter, E., Thomas, M., Wanyama, S., Vanderhelst, E., De Schutter, I., & Malfroot, A. (2016). WS23.2 Characterizing Belgian CF-registry (BCFR)-patients with a rare CFTR-mutation (RM): towards better identification of the role of RM in disease liability. Journal of Cystic Fibrosis, 15, S35. https://doi.org/10.1016/S1569-1993(16)30183-7

Chicago

De Wachter, E., M. Thomas, S. Wanyama, E. Vanderhelst, I. De Schutter, and A. Malfroot. 2016. “WS23.2 Characterizing Belgian CF-Registry (BCFR)-Patients with a Rare CFTR-Mutation (RM): Towards Better Identification of the Role of RM in Disease Liability.” Journal of Cystic Fibrosis 15 (June): S35. doi:10.1016/S1569-1993(16)30183-7.